Enzo Biochem, Inc.
ENZ was delisted on the 17th of April, 2025.
52 hedge funds and large institutions have $32.2M invested in Enzo Biochem, Inc. in 2013 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 20 reducing their positions, and 16 closing their positions.
17% more capital invested
Capital invested by funds: $27.5M → $32.2M (+$4.65M)
17% less funds holding
Funds holding: 63 → 52 (-11)
50% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 20
69% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 16
91% less call options, than puts
Call options by funds: $9K | Put options by funds: $95K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Verition Fund Management
Greenwich,
Connecticut
|
+$237K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$204K |
| 3 |
AA
Ancora Advisors
Cleveland,
Ohio
|
+$196K |
| 4 |
CCM
Corsair Capital Management
New York
|
+$185K |
| 5 |
Two Sigma Investments
New York
|
+$61K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
-$294K |
| 2 |
New York State Teachers Retirement System (NYSTRS)
Albany,
New York
|
-$268K |
| 3 |
APU
Alpine Partners USVI
St. Thomas,
U.S. Virgin Islands
|
-$230K |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$193K |
| 5 |
ClearBridge Investments
New York
|
-$184K |
ENZ Hedge Fund Activity: Q3 2013 in Review
52 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in Enzo Biochem, Inc. (ENZ) for Q3 2013, worth a combined $32.2M — up 17% from $27.5M a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of ENZ and 5 opened new positions — a net loss of 11 holders — while 20 trimmed existing stakes and 10 added.
The largest buyer was Verition Fund Management, opening a new position worth an estimated $237K. The largest seller was Ameriprise, cutting an estimated $294K.
- 52 institutional investors held Enzo Biochem, Inc. (ENZ) as of Q3 2013, down from 63 in Q2 2013.
- Funds reported $32.2M of Enzo Biochem, Inc. stock for Q3 2013, up 17% quarter-over-quarter.
- 5 funds opened new Enzo Biochem, Inc. positions in Q3 2013 and 16 closed out, a net change of -11 holders.
- The largest Enzo Biochem, Inc. buyer in Q3 2013 was Verition Fund Management, an estimated $237K added.
- The largest Enzo Biochem, Inc. seller in Q3 2013 was Ameriprise, an estimated $294K sold.
Based on aggregated 13F filings for Q3 2013.